APA (7th ed.) Citation

NV, M., AA, R., EV, P., VI, T., TI, E., AS, M., . . . EN, I. (2022). Comprehensive evaluation of the test for 5'-/3'-end mRNA unbalanced expression as a screening tool for ALK and ROS1 fusions in lung cancer. Cancer medicine, 11(17), 3226. https://doi.org/10.1002/cam4.4686

Chicago Style (17th ed.) Citation

NV, Mitiushkina, et al. "Comprehensive Evaluation of the Test for 5'-/3'-end MRNA Unbalanced Expression as a Screening Tool for ALK and ROS1 Fusions in Lung Cancer." Cancer Medicine 11, no. 17 (2022): 3226. https://doi.org/10.1002/cam4.4686.

MLA (9th ed.) Citation

NV, Mitiushkina, et al. "Comprehensive Evaluation of the Test for 5'-/3'-end MRNA Unbalanced Expression as a Screening Tool for ALK and ROS1 Fusions in Lung Cancer." Cancer Medicine, vol. 11, no. 17, 2022, p. 3226, https://doi.org/10.1002/cam4.4686.